Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology and risk factors of melanoma.
10.1016/j.suc.2019.09.005 · 2020 · External reference
Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.
10.2165/11589300-000000000-00000 · 2011 · External reference
Clinicopathological features, staging, and current approaches to treatment in high-risk resectable melanoma.
10.1093/jnci/djaa012 · 2020 · External reference
Evaluation of the agreement between TNM 7th and 8th in a population-based series of cutaneous melanoma.
10.1111/jdv.15285 · 2019 · External reference
A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome.
10.1038/s41431-020-0654-4 · 2020 · External reference
Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data.
10.1111/bjd.20658 · 2022 · External reference
Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review.
10.1111/bjd.13403 · 2015 · External reference
Guidelines for preventive activities in general practice.
2001 · External reference
Oncometabolites: unconventional triggers of oncogenic signalling cascades.
10.1016/j.freeradbiomed.2016.04.025 · 2016 · External reference
On the origin of cancer cells.
10.1126/science.123.3191.309 · 1956 · External reference
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers.
10.1016/j.ymthe.2021.03.003 · 2021 · External reference
PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers.
10.1016/j.cmet.2018.09.002 · 2019 · External reference
Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities.
10.1016/j.bbcan.2017.04.002 · 2017 · External reference
Recent advances in immunotherapy for the treatment of malignant melanoma.
10.2174/1381612828666220727124639 · 2022 · External reference
A role of immunotherapy in metastatic malignant melanoma.
10.2174/187152412802430165 · 2012 · External reference
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
10.1186/s13059-016-1028-7 · 2016 · External reference
Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment.
10.1158/0008-5472.can-16-2490 · 2017 · External reference
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
10.1093/annonc/mdz011 · 2019 · External reference
Five-year survival with combined nivolumab and ipilimumab in advanced melanoma.
10.1056/nejmoa1910836 · 2019 · External reference
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.
10.1038/s41591-019-0476-5 · 2019 · External reference
Neoadjuvant checkpoint immunotherapy and melanoma: the time is now.
10.1200/jco.22.02575 · 2023 · External reference
Emerging therapeutic targets for patients with advanced prostate cancer.
10.1016/j.ctrv.2019.03.002 · 2019 · External reference
Mechanisms and implications of metabolic heterogeneity in cancer.
10.1016/j.cmet.2019.08.013 · 2019 · External reference
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses.
10.1038/nri3701 · 2014 · External reference
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
10.1016/j.pharmthera.2008.09.005 · 2009 · External reference
Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma.
10.18632/aging.204748 · 2023 · External reference
Immunotherapy in the treatment of metastatic melanoma: current knowledge and future directions.
10.1155/2020/9235638 · 2020 · External reference
Melanoma treatment in review.
10.2147/itt.s134842 · 2018 · External reference
Tumor glycolysis as a target for cancer therapy: progress and prospects.
10.1186/1476-4598-12-152 · 2013 · External reference
Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
10.1016/j.ebiom.2019.03.068 · 2019 · External reference
CD4(+) T-cell differentiation and function: unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria.
10.1016/j.jaci.2021.03.033 · 2021 · External reference
Ablation of proton/glucose exporter SLC45A2 enhances melanosomal glycolysis to inhibit melanin biosynthesis and promote melanoma metastasis.
10.1016/j.jid.2022.04.008 · 2022 · External reference
Glycolysis regulator PFKP induces human melanoma cell proliferation and tumor growth.
10.1007/s12094-023-03096-7 · 2023 · External reference
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
10.7554/elife.73245 · 2022 · External reference
GOT2: an unexpected mediator of immunosuppression in pancreatic cancer.
10.1158/2159-8290.cd-22-0845 · 2022 · External reference
Combining single-cell and transcriptomic analysis revealed the immunomodulatory effect of GOT2 on a glutamine-dependent manner in cutaneous melanoma.
10.3389/fphar.2023.1241454 · 2023 · External reference
Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons.
10.1002/ana.10143 · 2002 · External reference
TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma.
10.1126/science.abq0607 · 2022 · External reference
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.
10.1016/j.cmet.2012.10.017 · 2012 · External reference
Metabolic reprogramming in metastatic melanoma with acquired resistance to targeted therapies: integrative metabolomic and proteomic analysis.
10.3390/cancers12051323 · 2020 · External reference
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
10.1186/s13046-023-02715-z · 2023 · External reference
Mucopolysaccharidoses type I gene therapy.
10.1002/jimd.12414 · 2021 · External reference
GYS1 induces glycogen accumulation and promotes tumor progression via the NF-kappaB pathway in clear cell renal carcinoma.
10.7150/thno.46825 · 2020 · External reference
A metabolism-driven prognostic model and PSMD14-SP1-GYS1 axis reveal therapeutic vulnerabilities in melanoma.
10.1016/j.jid.2025.08.044 · 2026 · External reference
Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
10.1038/s41586-019-1914-8 · 2020 · External reference
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.
10.1038/s41467-019-12160-2 · 2019 · External reference
Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients.
10.1093/cei/uxab005 · 2022 · External reference
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
10.1038/s41591-018-0198-0 · 2018 · External reference
Immunomodulation of the tumor microenvironment: turn foe into friend.
10.3389/fimmu.2018.02909 · 2018 · External reference
The role of myeloid-derived suppressor cells (MDSC) in cancer progression.
10.3390/vaccines4040036 · 2016 · External reference
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma.
10.1126/sciadv.adc8825 · 2023 · External reference
The clinical role of the TME in solid cancer.
10.1038/s41416-018-0327-z · 2019 · External reference
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma.
10.1186/s40425-019-0675-0 · 2019 · External reference
Melanoma.
10.1016/s0140-6736(18)31559-9 · 2018 · External reference
Treatment of metastatic uveal melanoma with intravenous fotemustine.
10.1097/cmr.0b013e3283610586 · 2013 · External reference
Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review.
10.1186/s40880-017-0179-6 · 2017 · External reference
